{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:54:42Z","timestamp":1791093282126,"version":"4.1.0"},"reference-count":148,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2010,11,16]],"date-time":"2010-11-16T00:00:00Z","timestamp":1289865600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cell. Mol. Life Sci."],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00018-010-0584-3","type":"journal-article","created":{"date-parts":[[2010,11,15]],"date-time":"2010-11-15T22:44:05Z","timestamp":1289861045000},"page":"433-451","source":"Crossref","is-referenced-by-count":64,"title":["Emerging topics and new perspectives on HLA-G"],"prefix":"10.1007","volume":"68","author":[{"given":"Enrico","family":"Fainardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Castellazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Stignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Morandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwena\u00eblle","family":"Sana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vito","family":"Pistoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavio Roberto","family":"Baricordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etienne","family":"Sokal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e8","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,16]]},"reference":[{"key":"584_CR1","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.it.2007.11.005","volume":"3","author":"ED Carosella","year":"2008","unstructured":"Carosella ED, Moreau P, LeMaoult J, Rouas-Freiss N (2008) HLA-G: from biology to clinical benefits. Trends Immunol 3:125\u2013132","journal-title":"Trends Immunol"},{"key":"584_CR2","doi-asserted-by":"crossref","first-page":"4862","DOI":"10.1182\/blood-2007-12-127662","volume":"111","author":"ED Carosella","year":"2008","unstructured":"Carosella ED, Favier B, Rouas-Freiss N, Moreau P, LeMaoult J (2008) Beyond the increasing complexity of the immunomodulatory HLA-G molecules. Blood 111:4862\u20134870","journal-title":"Blood"},{"key":"584_CR3","doi-asserted-by":"crossref","first-page":"3947","DOI":"10.1073\/pnas.89.9.3947","volume":"89","author":"A Ishitani","year":"1992","unstructured":"Ishitani A, Gerarthy DE (1992) Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci USA 89:3947\u20133951","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR4","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0198-8859(00)00197-X","volume":"61","author":"P Paul","year":"2000","unstructured":"Paul P, Cabestre FA, Ibrahim EC, Lefevbre S, Khalil-Daher I, Vazeux G, Quiles RM, Bermond F, Dausset J, Carosella ED (2000) Identification of HLA-G7 as a new slice variant of the HLA-G mRNA and expression of soluble HL-G5, -G6, and -G7 transcripts in human transfected cells. Hum Immunol 61:1138\u20131149","journal-title":"Hum Immunol"},{"key":"584_CR5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1126\/science.2326636","volume":"144","author":"S Kovats","year":"1990","unstructured":"Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R (1990) A class I antigen, HL-G, expressed in human trophoblasts. Science 144:220\u2013223","journal-title":"Science"},{"key":"584_CR6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1034\/j.1399-0039.2003.00143.x","volume":"62","author":"J LeMaoult","year":"2003","unstructured":"LeMaoult J, Le Discorde M, Rouas-Freiss N, Moreau P, Menier C, McCluskey J, Carosella ED (2003) Biology and functions of human leukocyte antigen-G in health and sickness. Tissue Antigens 62:273\u2013284","journal-title":"Tissue Antigens"},{"key":"584_CR7","doi-asserted-by":"crossref","first-page":"731","DOI":"10.4049\/jimmunol.144.2.731","volume":"144","author":"SA Ellis","year":"1990","unstructured":"Ellis SA, Palmer LS, McMichael AJ (1990) Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA class I molecule. J Immunol 144:731\u2013735","journal-title":"J Immunol"},{"key":"584_CR8","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/intimm\/11.6.889","volume":"11","author":"V Mallet","year":"1999","unstructured":"Mallet V, Blaschitz A, Crisa L, Schmitt C, Fournel S, King A, Loke YW, Dohr G, Le Bouteiller P (1999) HLA-G in the human thymus: a subpopulation of medullary epithelial but not CD83(+) dendritic cells expresses HLA-G as a membrane-bound and soluble protein. Int Immunol 11:889\u2013898","journal-title":"Int Immunol"},{"key":"584_CR9","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.humimm.2003.08.346","volume":"64","author":"M Le Discorde","year":"2003","unstructured":"Le Discorde M, Moreau P, Sabatier P, Legeais JM, Carosella ED (2003) Expression of HLA-G in human cornea, an immune-privileged tissue. Hum Immunol 64:1039\u20131044","journal-title":"Hum Immunol"},{"key":"584_CR10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.0022-202X.2005.23927.x","volume":"125","author":"T Ito","year":"2005","unstructured":"Ito T, Ito N, Saathoff M, Stampachiacchiere B, Bettermann A, Bulfone-Paus S, Takigawa M, Nickoloff BJ, Paus R (2005) Immunology of the human nail apparatus: the nail matrix is a site of relative immune privilege. J Invest Dermatol 125:1139\u20131148","journal-title":"J Invest Dermatol"},{"key":"584_CR11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/db05-0731","volume":"55","author":"V Cirulli","year":"2006","unstructured":"Cirulli V, Zalatan J, McMaster M, Prinsen R, Salomon DR, Ricordi C, Torbett BE, Meda P, Crisa L (2006) The class I HLA repertoire of pancreatic islets comprises the nonclassical class Ib antigen HLA-G. Diabetes 55:1214\u20131222","journal-title":"Diabetes"},{"key":"584_CR12","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1182\/blood-2004-03-0809","volume":"104","author":"C Menier","year":"2004","unstructured":"Menier C, Rabreau M, Challier JC, Le Discorde M, Carosella ED, Rouas-Freiss N (2004) Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104:3153\u20133160","journal-title":"Blood"},{"key":"584_CR13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/intimm\/11.5.803","volume":"11","author":"P Moreau","year":"1999","unstructured":"Moreau P, Adrian-Cabestre F, Menier C, Guiard V, Gourand L, Dausset J, Carosella ED, Paul P (1999) IL-10 selectively induces HLA-G expression in human trophoblasts and monocytes. Int Immunol 11:803\u2013811","journal-title":"Int Immunol"},{"key":"584_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.humimm.2006.10.012","volume":"68","author":"R Rizzo","year":"2007","unstructured":"Rizzo R, Melchiorri L, Stignani M, Baricordi OR (2007) HLA-G expression is a fundamental prerequisite to pregnancy. Hum Immunol 68:244\u2013250","journal-title":"Hum Immunol"},{"key":"584_CR15","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1161\/01.CIR.0000015075.89984.46","volume":"105","author":"N Lila","year":"2002","unstructured":"Lila N, Amrein C, Guillemain R, Chevalier P, Latremouille C, Fabiani JN, Dausset J, Carosella ED, Carpentier A (2002) Human leukocyte antigen-G expression after heart transplantation is associated with a reduced incidence of rejection. Circulation 105:1949\u20131954","journal-title":"Circulation"},{"key":"584_CR16","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.semcancer.2007.07.004","volume":"17","author":"V Pistoia","year":"2007","unstructured":"Pistoia V, Morandi F, Wang X, Ferrone S (2007) Soluble HLA-G: are they clinically relevant? Semin Cancer Biol 17:469\u2013479","journal-title":"Semin Cancer Biol"},{"key":"584_CR17","doi-asserted-by":"crossref","first-page":"4510","DOI":"10.1073\/pnas.95.8.4510","volume":"95","author":"P Paul","year":"1998","unstructured":"Paul P, Rouas-Freiss N, Khalil-Daher I, Moreau P, Riteau B, Le Gal FA, Avril MF, Dausset J, Guillet JG, Carosella ED (1998) HLA-G expression in melanoma: a way for tumor cells to escape from immunosurveillance. Proc Natl Acad Sci USA 95:4510\u20134515","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR18","doi-asserted-by":"crossref","first-page":"6426","DOI":"10.4049\/jimmunol.164.12.6426","volume":"164","author":"M Onno","year":"2000","unstructured":"Onno M, Pangault C, Le Friec G, Guilloux V, Andre P, Fauchet R (2000) Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol 164:6426\u20136434","journal-title":"J Immunol"},{"key":"584_CR19","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1073\/pnas.94.10.5249","volume":"94","author":"N Rouas-Freiss","year":"1997","unstructured":"Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED (1997) The \u03b11 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci USA 94:5249\u20135254","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR20","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.4049\/jimmunol.164.12.6100","volume":"164","author":"S Fournel","year":"2000","unstructured":"Fournel S, Aguerre-Gir M, Huc X, Lenfant F, Alam A, Toubert A, Bensussan A, Le Bouteiller P (2000) Cutting edge: soluble HLA-G1 triggers CD95\/CD 95 ligand-mediated apoptosis in activated CD8+ cells by interacting CD8. J Immunol 164:6100\u20136104","journal-title":"J Immunol"},{"key":"584_CR21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/immu.200390015","volume":"33","author":"P Contini","year":"2003","unstructured":"Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F (2003) Soluble HLA-A, -B, -C, and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation. Eur J Immunol 33:125\u2013134","journal-title":"Eur J Immunol"},{"key":"584_CR22","doi-asserted-by":"crossref","first-page":"12150","DOI":"10.1073\/pnas.201407398","volume":"98","author":"N Lila","year":"2001","unstructured":"Lila N, Rouas-Freiss N, Dausset J, Carpentier A, Carosella ED (2001) Soluble HLA-G protein secreted by allo-specific CD4+ T cells suppresses the allo-proliferative response: a CD4+ T cell regulatory mechanism. Proc Natl Acad Sci USA 98:12150\u201312155","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR23","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.4049\/jimmunol.176.5.3266","volume":"176","author":"S Le Rond","year":"2006","unstructured":"Le Rond S, Az\u00e8ma C, Krawice-Radanne I, Durrbach A, Guettier C, Carosella ED, Rouas-Freiss N (2006) Evidence to support the role of HLA-G5 in allograft acceptance through induction of immunosuppressive\/regulatory T cells. J Immunol 176:3266\u20133276","journal-title":"J Immunol"},{"key":"584_CR24","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/intimm\/13.3.385","volume":"13","author":"A Horuzsko","year":"2001","unstructured":"Horuzsko A, Lenfant F, Munn DH, Mellor AL (2001) Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 13:385\u2013394","journal-title":"Int Immunol"},{"key":"584_CR25","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1084\/jem.186.11.1809","volume":"186","author":"M Colonna","year":"1997","unstructured":"Colonna M, Navarro F, Bell\u00f3n T, Llano M, Garc\u00eda P, Samaridis J, Angman L, Cella M, L\u00f3pez-Botet M (1997) A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med 186:1809\u20131818","journal-title":"J Exp Med"},{"key":"584_CR26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2567.2000.00109.x","volume":"101","author":"K Kapasi","year":"2000","unstructured":"Kapasi K, Albert SE, Yie S, Zavazava N, Librach CL (2000) HLA-G has a concentration-dependent effect on the generation of an allo-CTL response. Immunology 101:191\u2013200","journal-title":"Immunology"},{"key":"584_CR27","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/molehr\/7.2.195","volume":"7","author":"T Kanai","year":"2001","unstructured":"Kanai T, Fujii T, Kozuma S, Yamashita T, Miki A, Kikuchi A, Taketani Y (2001) Soluble HLA-G influences the release of cytokines from allogeneic peripheral blood mononuclear cells in culture. Mol Hum Reprod 7:195\u2013200","journal-title":"Mol Hum Reprod"},{"key":"584_CR28","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2006-05-024547","volume":"109","author":"J LeMaoult","year":"2007","unstructured":"LeMaoult J, Caumartin J, Daouya M, Favier B, Le Rond S, Gonzalez A, Carosella ED (2007) Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 109:2040\u20132048","journal-title":"Blood"},{"key":"584_CR29","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1096\/fj.04-1617fje","volume":"19","author":"J LeMaoult","year":"2005","unstructured":"LeMaoult J, Zafaranloo K, Le Danff C, Carosella ED (2005) HLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cells. FASEB J 19:662\u2013664","journal-title":"FASEB J"},{"key":"584_CR30","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/S1471-4906(01)02007-5","volume":"22","author":"ED Carosella","year":"2001","unstructured":"Carosella ED, Moreau P, Aractingi S, Rouas-Freiss N (2001) HLA-G: a shield against inflammatory aggression. Trends Immunol 22:553\u2013555","journal-title":"Trends Immunol"},{"key":"584_CR31","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.23.021704.115707","volume":"23","author":"M Sospedra","year":"2005","unstructured":"Sospedra M, Martin R (2005) Immunology of multiple sclerosis. Annu Rev Immunol 23:683\u2013747","journal-title":"Annu Rev Immunol"},{"key":"584_CR32","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517","journal-title":"Lancet"},{"key":"584_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS (2001) Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121\u2013127","journal-title":"Ann Neurol"},{"key":"584_CR34","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0165-5728(03)00266-2","volume":"142","author":"E Fainardi","year":"2003","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Vaghi L, Castellazzi M, Marzola A, Govoni V, Paolino E, Tola MR, Granieri E, Baricordi OR (2003) Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings. J Neuroimmunol 142:149\u2013158","journal-title":"J Neuroimmunol"},{"key":"584_CR35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1191\/1352458506ms1241oa","volume":"12","author":"E Fainardi","year":"2006","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Paolino E, Tola MR, Granieri E, Baricordi OR (2006) Intrathecal synthesis of soluble HLA-G and HLA-I molecules are reciprocally associated to clinical and MRI activity in patients with multiple sclerosis. Mult Scler 12:2\u201312","journal-title":"Mult Scler"},{"key":"584_CR36","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jneuroim.2007.10.002","volume":"192","author":"E Fainardi","year":"2007","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Caniatti ML, Baldi E, Tola MR, Granieri E, Baricordi OR (2007) Soluble HLA-G molecules are released as HLA-G5 and not as soluble HLA-G1 isoforms in CSF of patients with relapsing-remitting multiple sclerosis. J Neuroimmunol 192:219\u2013225","journal-title":"J Neuroimmunol"},{"key":"584_CR37","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1177\/1352458507085137","volume":"14","author":"E Fainardi","year":"2008","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Stignani M, Castellazzi M, Tamborino C, Paolino E, Tola MR, Granieri E, Baricordi OR (2008) CSF levels of soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing remitting multiple sclerosis. Mult Scler 14:446\u2013454","journal-title":"Mult Scler"},{"key":"584_CR38","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneuroim.2003.12.002","volume":"148","author":"E Fainardi","year":"2004","unstructured":"Fainardi E, Rizzo R, Melchiorri L, Castellazzi M, Govoni V, Caniatti L, Paolino E, Tola MR, Granieri E, Baricordi OR (2004) Beneficial effect of interferon-\u03b2 1b treatment in patients with relapsing-remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3\u00a0months of therapy. J Neuroimmunol 148:206\u2013211","journal-title":"J Neuroimmunol"},{"key":"584_CR39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2004.09.016","volume":"159","author":"M Mitsdoerffer","year":"2005","unstructured":"Mitsdoerffer M, Schreiner B, Kieseier B, Neuhaus O, Dichgans J, Hartung H-P, Weller M, Wiendl H (2005) Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-\u03b2 in vitro and in vivo: rationale for the therapy of multiple sclerosis. J Neuroimmunol 159:155\u2013164","journal-title":"J Neuroimmunol"},{"key":"584_CR40","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1093\/brain\/awh609","volume":"128","author":"H Wiendl","year":"2005","unstructured":"Wiendl H, Feger U, Mittelbronn M, Jack C, Schreiner B, Stadelmann C, Antel J, Brueck W, Meyermann R, Bar-Or A, Kieseier BC, Weller M (2005) Expression of the immune-tolerogenic major histocompatibility molecule HLA-G in multiple sclerosis: implications for CNS immunity. Brain 128:2689\u20132704","journal-title":"Brain"},{"key":"584_CR41","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1182\/blood-2006-11-057125","volume":"110","author":"U Feger","year":"2007","unstructured":"Feger U, Tolosa E, Huang YH, Waschbisch A, Biedermann T, Melms A, Wiendl H (2007) HLA-G expression defines a novel regulatory T cell subset present in human peripheral blood and sites of inflammation. Blood 110:568\u2013577","journal-title":"Blood"},{"key":"584_CR42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1189\/jlb.1008649","volume":"86","author":"YH Huang","year":"2009","unstructured":"Huang YH, Zozulya AL, Weidenfeller C, Schwab N, Wiendl H (2009) T cell suppression by naturally occurring HLA-G-expressing regulatory CD4+ T cells is IL-10 dependent and reversible. J Leukoc Biol 86:273\u2013281","journal-title":"J Leukoc Biol"},{"key":"584_CR43","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/ana.21705","volume":"66","author":"YH Huang","year":"2009","unstructured":"Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Br\u00fcck W, Wiendl H (2009) Specific central nervous system recruitment of HLA-G (+) regulatory T cells in multiple sclerosis. Ann Neurol 66:171\u2013183","journal-title":"Ann Neurol"},{"key":"584_CR44","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humimm.2009.07.014","volume":"70","author":"E Fainardi","year":"2009","unstructured":"Fainardi E, Rizzo R, Castellazzi M, Stignani M, Granieri E, Baricordi OR (2009) Potential role of soluble human leukocyte antigen-G molecules in multiple sclerosis. Hum Immunol 70:981\u2013987","journal-title":"Hum Immunol"},{"key":"584_CR45","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S1474-4422(05)70195-2","volume":"4","author":"SA Mayer","year":"2005","unstructured":"Mayer SA, Rincon F (2005) Treatment of intracerebral haemorrhage. Lancet Neurol 4:662\u2013672","journal-title":"Lancet Neurol"},{"key":"584_CR46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S1474-4422(05)70283-0","volume":"5","author":"G Xi","year":"2006","unstructured":"Xi G, Keep RF, Hoff JT (2006) Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 5:53\u201363","journal-title":"Lancet Neurol"},{"key":"584_CR47","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/sj.jcbfm.9600357","volume":"27","author":"J Wang","year":"2007","unstructured":"Wang J, Dor\u00e9 S (2007) Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 27:894\u2013908","journal-title":"J Cereb Blood Flow Metab"},{"issue":"Suppl","key":"584_CR48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/978-3-211-98811-4_25","volume":"106","author":"E Fainardi","year":"2010","unstructured":"Fainardi E, Rizzo R, Lupato A, Ramponi V, De Santis G, Garofano F, Stignani M, Tamborino C, Castellazzi M, Casetta I, Baricordi OR (2010) Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. Acta Neurochir 106(Suppl):141\u2013145","journal-title":"Acta Neurochir"},{"key":"584_CR49","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1161\/STROKEAHA.107.500876","volume":"39","author":"P Delgado","year":"2008","unstructured":"Delgado P, Cuadrado E, Rosell A, Alvarez-Sab\u00edn J, Ortega-Aznar A, Hern\u00e1ndez-Guillam\u00f3n M, Penalba A, Molina CA, Montaner J (2008) Fas system activation in perihematomal areas after spontaneous intracerebral hemorrhage. Stroke 39:1730\u20131734","journal-title":"Stroke"},{"key":"584_CR50","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/17402520400004201","volume":"11","author":"Z Wen","year":"2004","unstructured":"Wen Z, Fiocchi C (2004) Inflammatory bowel disease: autoimmune or immune-mediated pathogenesis? Clin Dev Immunol 11:195\u2013204","journal-title":"Clin Dev Immunol"},{"key":"584_CR51","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/intimm\/dxh061","volume":"16","author":"MI Torres","year":"2004","unstructured":"Torres MI, Le Discorde M, Lorite P, R\u00edos A, Gassull MA, Gil A, Maldonado J, Dausset J, Carosella ED (2004) Expression of HLA-G in inflammatory bowel disease provides a potential way to distinguish between ulcerative colitis and Crohn\u2019s disease. Int Immunol 16:579\u2013583","journal-title":"Int Immunol"},{"key":"584_CR52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ibd.20281","volume":"14","author":"R Rizzo","year":"2008","unstructured":"Rizzo R, Melchiorri L, Simone L, Stignani M, Marzola A, Gullini S, Baricordi OR (2008) Different production of soluble HLA-G antigens by peripheral blood mononuclear cells in ulcerative colitis and Crohn\u2019s disease: a noninvasive diagnostic tool? Inflamm Bowel Dis 14:100\u2013105","journal-title":"Inflamm Bowel Dis"},{"key":"584_CR53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00251-003-0547-z","volume":"55","author":"TV Hviid","year":"2003","unstructured":"Hviid TV, Hylenius S, Rorbye C, Nielsen LG (2003) HLA-G allelic variants are associated with differences in the HLA-G mRNA isoform profile and HLA-G mRNA levels. Immunogenetics 55:63\u201379","journal-title":"Immunogenetics"},{"key":"584_CR54","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1093\/intimm\/dxm027","volume":"19","author":"J Glas","year":"2007","unstructured":"Glas J, T\u00f6r\u00f6k HP, Tonenchi L, Wetzke M, Beynon V, Teshome MY, Cotofana S, Schiemann U, Griga T, Klein W, Epplen JT, Folwaczny C, Folwaczny M, Mussack T, Weiss EH (2007) The 14\u00a0bp deletion polymorphism in the HLA-G gene displays significant differences between ulcerative colitis and Crohn\u2019s disease and is associated with ileocecal resection in Crohn\u2019s disease. Int Immunol 19:621\u2013626","journal-title":"Int Immunol"},{"key":"584_CR55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/intimm\/dxl008","volume":"18","author":"MI Torres","year":"2006","unstructured":"Torres MI, L\u00f3pez-Casado MA, Luque J, Pe\u00f1a J, R\u00edos A (2006) New advances in coeliac disease: serum and intestinal expression of HLA-G. Int Immunol 18:713\u2013718","journal-title":"Int Immunol"},{"key":"584_CR56","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.semcancer.2007.09.001","volume":"17","author":"M Urosevic","year":"2007","unstructured":"Urosevic M (2007) HLA-G in the skin\u2013friend or foe? Semin Cancer Biol 17:480\u2013484","journal-title":"Semin Cancer Biol"},{"key":"584_CR57","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0002-9440(10)61675-6","volume":"159","author":"S Aractingi","year":"2001","unstructured":"Aractingi S, Briand N, Le Danff C, Viguier M, Bachelez H, Michel L, Dubertret L, Carosella ED (2001) HLA-G and NK receptor are expressed in psoriatic skin: a possible pathway for regulating infiltrating T cells? Am J Pathol 159:71\u201377","journal-title":"Am J Pathol"},{"key":"584_CR58","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00403-008-0886-6","volume":"300","author":"A Borghi","year":"2008","unstructured":"Borghi A, Fogli E, Stignani M, Melchiorri L, Altieri E, Baricordi O, Rizzo R, Virgili A (2008) Soluble human leukocyte antigen-G and interleukin-10 levels in plasma of psoriatic patients: preliminary study on a possible correlation between generalized immune status, treatments and disease. Arch Dermatol Res 300:551\u2013559","journal-title":"Arch Dermatol Res"},{"key":"584_CR59","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1046\/j.0022-202x.2001.01487.x","volume":"117","author":"K Khosrotehrani","year":"2001","unstructured":"Khosrotehrani K, Le Danff C, Reynaud-Mendel B, Dubertret L, Carosella ED, Aractingi S (2001) HLA-G expression in atopic dermatitis. J Invest Dermatol 117:750\u2013752","journal-title":"J Invest Dermatol"},{"key":"584_CR60","first-page":"7","volume":"7","author":"F Yari","year":"2008","unstructured":"Yari F, Zavaran Hosseini A, Nemat Gorgani M, Khorramizadeh MR, Mansouri P, Kazemnejad A (2008) Expression of HLA-G in the skin of patients with pemphigus vulgaris. Iran J Allergy Asthma Immunol 7:7\u201312","journal-title":"Iran J Allergy Asthma Immunol"},{"key":"584_CR61","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.humimm.2003.09.019","volume":"65","author":"E Gazit","year":"2004","unstructured":"Gazit E, Slomov Y, Goldberg I, Brenner S, Loewenthal R (2004) HLA-G is associated with pemphigus vulgaris in Jewish patients. Hum Immunol 65:39\u201346","journal-title":"Hum Immunol"},{"key":"584_CR62","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.humimm.2006.03.023","volume":"67","author":"LA Verbruggen","year":"2006","unstructured":"Verbruggen LA, Rebmann V, Demanet C, De Cock S, Grosse-Wilde H (2006) Soluble HLA-G in rheumatoid arthritis. Hum Immunol 67:561\u2013567","journal-title":"Hum Immunol"},{"key":"584_CR63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874312900802010081","volume":"2","author":"M Feuchtenberger","year":"2008","unstructured":"Feuchtenberger M, M\u00fcller S, Roll P, Waschbisch A, Sch\u00e4fer A, Kneitz C, Wiendl H, Tony HP (2008) Frequency of regulatory T cells is not affected by transient B cell depletion using anti-CD20 antibodies in rheumatoid arthritis. Open Rheumatol J 2:81\u201388","journal-title":"Open Rheumatol J"},{"key":"584_CR64","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/01.fpc.0000230115.41828.3a","volume":"16","author":"R Rizzo","year":"2006","unstructured":"Rizzo R, Rubini M, Govoni M, Padovan M, Melchiorri L, Stignani M, Carturan S, Ferretti S, Trotta F, Baricordi OR (2006) HLA-G 14\u00a0bp polymorphism regulates the methotrexate response in rheumatoid arthritis. Pharmacogenet Genomics 16:615\u2013623","journal-title":"Pharmacogenet Genomics"},{"key":"584_CR65","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/j.1399-0039.2008.01019.x","volume":"71","author":"TD Veit","year":"2008","unstructured":"Veit TD, Vianna P, Scheibel I, Brenol CV, Brenol JC, Xavier RM, Delgado-Ca\u00f1edo A, Gutierrez JE, Brandalize AP, Schuler-Faccini L, Chies JA (2008) Association of the HLA-G 14\u00a0bp insertion\/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis. Tissue Antigens 71:440\u2013446 Erratum in: Tissue Antigens 72, 185","journal-title":"Tissue Antigens"},{"key":"584_CR66","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humimm.2007.11.001","volume":"69","author":"S Rosado","year":"2008","unstructured":"Rosado S, Perez-Chacon G, Mellor-Pita S, Sanchez-Vegazo I, Bellas-Menendez C, Citores MJ, Losada-Fernandez I, Martin-Donaire T, Rebolleda N, Perez-Aciego P (2008) Expression of human leukocyte antigen-G in systemic lupus erythematosus. Hum Immunol 69:9\u201315","journal-title":"Hum Immunol"},{"key":"584_CR67","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1111\/j.1399-0039.2008.01037.x","volume":"71","author":"R Rizzo","year":"2008","unstructured":"Rizzo R, Hviid TV, Govoni M, Padovan M, Rubini M, Melchiorri L, Stignani M, Carturan S, Grappa MT, Fotinidi M, Ferretti S, Voss A, Laustrup H, Junker P, Trotta F, Baricordi OR (2008) HLA-G genotype and HLA-G expression in systemic lupus erythematosus: HLA-G as a putative susceptibility gene in systemic lupus erythematosus. Tissue Antigens 71:520\u2013529","journal-title":"Tissue Antigens"},{"key":"584_CR68","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/0961203308098187","volume":"18","author":"TD Veit","year":"2009","unstructured":"Veit TD, Cordero EA, Mucenic T, Monticielo OA, Brenol JC, Xavier RM, Delgado-Ca\u00f1edo A, Chies JA (2009) Association of the HLA-G 14\u00a0bp polymorphism with systemic lupus erythematosus. Lupus 18:424\u2013430","journal-title":"Lupus"},{"key":"584_CR69","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1177\/0961203309345756","volume":"18","author":"FX Wu","year":"2009","unstructured":"Wu FX, Wu LJ, Luo XY, Tang Z, Yang MH, Xie CM, Liu NT, Zhou JG, Guan JL, Yuan GH (2009) Lack of association between HLA-G 14\u00a0bp polymorphism and systemic lupus erythematosus in a Han Chinese population. Lupus 18:1259\u20131266","journal-title":"Lupus"},{"key":"584_CR70","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jaci.2004.11.031","volume":"115","author":"R Rizzo","year":"2005","unstructured":"Rizzo R, Mapp CE, Melchiorri L, Maestrelli P, Visentin A, Ferretti S, Bononi I, Miotto D, Baricordi OR (2005) Defective production of soluble HLA-G molecules by peripheral blood monocytes in patients with asthma. J Allergy Clin Immunol 115:508\u2013513","journal-title":"J Allergy Clin Immunol"},{"key":"584_CR71","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000095290","volume":"141","author":"F Tahan","year":"2006","unstructured":"Tahan F, Patiroglu T (2006) Plasma soluble human leukocyte antigen G levels in asthmatic children. Int Arch Allergy Immunol 141:213\u2013216","journal-title":"Int Arch Allergy Immunol"},{"key":"584_CR72","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1086\/427763","volume":"76","author":"D Nicolae","year":"2005","unstructured":"Nicolae D, Cox NJ, Lester LA, Schneider D, Tan Z, Billstrand C, Kuldanek S, Donfack J, Kogut P, Patel NM, Goodenbour J, Howard T, Wolf R, Koppelman GH, White SR, Parry R, Postma DS, Meyers D, Bleecker ER, Hunt JS, Solway J, Ober C (2005) Fine mapping and positional candidate studies identify HLA-G as an asthma susceptibility gene on chromosome 6p21. Am J Hum Genet 76:349\u2013357","journal-title":"Am J Hum Genet"},{"key":"584_CR73","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/521200","volume":"81","author":"Z Tan","year":"2007","unstructured":"Tan Z, Randall G, Fan J, Camoretti-Mercado B, Brockman-Schneider R, Pan L, Solway J, Gern JE, Lemanske RF, Nicolae D, Ober C (2007) Allele-specific targeting of microRNAs to HLA-G and risk of asthma. Am J Hum Genet 81:829\u2013834","journal-title":"Am J Hum Genet"},{"key":"584_CR74","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/j.1365-2222.2009.03215.x","volume":"39","author":"CE Mapp","year":"2009","unstructured":"Mapp CE, Ferrazzoni S, Rizzo R, Miotto D, Stignani M, Boschetto P, Maestrelli P, Baricordi OR (2009) Soluble human leucocyte antigen-G and interleukin-10 levels in isocyanate-induced asthma. Clin Exp Allergy 39:812\u2013819","journal-title":"Clin Exp Allergy"},{"key":"584_CR75","doi-asserted-by":"crossref","first-page":"8357","DOI":"10.1073\/pnas.0803341105","volume":"105","author":"S Liang","year":"2008","unstructured":"Liang S, Ristich V, Arase H, Dausset J, Carosella ED, Horuzsko A (2008) Modulation of dendritic cell differentiation by HLA-G and ILT4 requires the IL-6\u2013STAT3 signaling pathway. Proc Natl Acad Sci USA 105:8357\u20138362","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR76","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.4049\/jimmunol.173.6.3844","volume":"173","author":"SJ Park","year":"2004","unstructured":"Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, Sawa S, Kamimura D, Ueda N, Iwakura Y, Ishihara K, Murakami M, Hirano T (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173:3844\u20133854","journal-title":"J Immunol"},{"key":"584_CR77","doi-asserted-by":"crossref","first-page":"5767","DOI":"10.1073\/pnas.0901173106","volume":"106","author":"C Li","year":"2009","unstructured":"Li C, Houser BL, Nicotra ML, Strominger JL (2009) HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells. Proc Natl Acad Sci USA 106:5767\u20135772","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR78","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1371\/journal.pbio.0040009","volume":"4","author":"S Rajagopalan","year":"2006","unstructured":"Rajagopalan S, Bryceson YT, Kuppusamy SP, Geraghty DE, van der Meer A, Joosten I, Long EO (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol 4:e9","journal-title":"PLoS Biol"},{"key":"584_CR79","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/molehr\/gal100","volume":"13","author":"A Meer van der","year":"2007","unstructured":"van der Meer A, Lukassen HG, van Cranenbroek B, Weiss EH, Braat DD, van Lierop MJ, Joosten I (2007) Soluble HLA-G promotes Th1-type cytokine production by cytokine-activated uterine and peripheral natural killer cells. Mol Hum Reprod 13:123\u2013133","journal-title":"Mol Hum Reprod"},{"key":"584_CR80","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.181.4.2368","volume":"181","author":"E Morel","year":"2008","unstructured":"Morel E, Bellon T (2008) HLA class I molecules regulate IFN-gamma production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2\/CD85j. J Immunol 181:2368\u20132381","journal-title":"J Immunol"},{"key":"584_CR81","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1189\/jlb.0604337","volume":"76","author":"RH McIntire","year":"2004","unstructured":"McIntire RH, Morales PJ, Petroff MG, Colonna M, Hunt JS (2004) Recombinant HLA-G5 and -G6 drive U937 myelomonocytic cell production of TGF-beta1. J Leukoc Biol 76:1220\u20131228","journal-title":"J Leukoc Biol"},{"key":"584_CR82","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1084\/jem.184.2.539","volume":"184","author":"I Roth","year":"1996","unstructured":"Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ, Fisher SJ (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. J Exp Med 184:539\u2013548","journal-title":"J Exp Med"},{"key":"584_CR83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S1044-579X(03)00024-5","volume":"13","author":"M Urosevic","year":"2003","unstructured":"Urosevic M, Dummer R (2003) HLA-G and IL-10 expression in human cancer-different stories with the same message. Semin Cancer Biol 13:337\u2013342","journal-title":"Semin Cancer Biol"},{"key":"584_CR84","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1182\/blood-2007-04-083139","volume":"110","author":"A Naji","year":"2007","unstructured":"Naji A, Le Rond S, Durrbach A, Krawice-Radanne I, Creput C, Daouya M, Caumartin J, LeMaoult J, Carosella ED, Rouas-Freiss N (2007) CD3+ CD4low and CD3+ CD8low are induced by HLA-G: novel human peripheral blood suppressor T cell subsets involved in transplant acceptance. Blood 110:3936\u20134398","journal-title":"Blood"},{"key":"584_CR85","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.intimp.2009.04.014","volume":"9","author":"G Ciprandi","year":"2009","unstructured":"Ciprandi G, Contini P, Murdaca G, DeAmici M, Gallina AM, Puppo F (2009) Soluble serum HLA-G and HLA-A, -B, -C molecules in patients with seasonal allergic rhinitis exposed to pollens. Int Immunopharmacol 9:1058\u20131062","journal-title":"Int Immunopharmacol"},{"key":"584_CR86","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.humimm.2008.05.009","volume":"69","author":"G Ciprandi","year":"2008","unstructured":"Ciprandi G, Contini P, Fenoglio D, Sormani MP, Negrini S, Puppo F, Indiveri F (2008) Relationship between soluble HLA-G and HLA-A, -B, -C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis. Hum Immunol 69:409\u2013413","journal-title":"Hum Immunol"},{"key":"584_CR87","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S, Marshak DR (1999) Multilineage potential of adult human mesenchymal stem cells. Science 284:143\u2013147","journal-title":"Science"},{"key":"584_CR88","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.1002\/eji.200636416","volume":"36","author":"A Uccelli","year":"2006","unstructured":"Uccelli A, Moretta L, Pistoia V (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 36:2566\u20132573","journal-title":"Eur J Immunol"},{"key":"584_CR89","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","volume":"8","author":"A Uccelli","year":"2008","unstructured":"Uccelli A, Moretta L, Pistoia V (2008) Mesenchymal stem cells in health and disease. Nat Rev Immunol 8:726\u2013736","journal-title":"Nat Rev Immunol"},{"key":"584_CR90","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.it.2007.03.001","volume":"28","author":"A Uccelli","year":"2007","unstructured":"Uccelli A, Pistoia V, Moretta L (2007) Mesenchymal stem cells: a new strategy for immunosuppression? Trends Immunol 28:219\u2013226","journal-title":"Trends Immunol"},{"key":"584_CR91","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1182\/blood-2004-04-1559","volume":"105","author":"S Aggarwal","year":"2005","unstructured":"Aggarwal S, Pittenger MF (2005) Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood 105:1815\u20131822","journal-title":"Blood"},{"key":"584_CR92","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1182\/blood-2005-07-2657","volume":"107","author":"A Corcione","year":"2006","unstructured":"Corcione A, Benvenuto F, Ferretti E, Giunti D, Cappiello V, Cazzanti F, Risso M, Gualandi F, Mancardi GL, Pistoia V, Uccelli A (2006) Human mesenchymal stem cells modulate B cell functions. Blood 107:367\u2013372","journal-title":"Blood"},{"key":"584_CR93","doi-asserted-by":"crossref","first-page":"4120","DOI":"10.1182\/blood-2004-02-0586","volume":"105","author":"XX Jiang","year":"2005","unstructured":"Jiang XX, Zhang Y, Liu B, Zhang SX, Wu Y, Yu XD, Mao N (2005) Human mesenchymal stem cells inhibit differentiation and function of monocyte-derived dendritic cells. Blood 105:4120\u20134126","journal-title":"Blood"},{"key":"584_CR94","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","volume":"107","author":"GM Spaggiari","year":"2006","unstructured":"Spaggiari GM, Capobianco A, Becchetti S, Mingari MC, Moretta L (2006) Mesenchymal stem cell-natural killer cell interactions: evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK cell proliferation. Blood 107:1484\u20131490","journal-title":"Blood"},{"key":"584_CR95","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1634\/stemcells.2007-0878","volume":"26","author":"F Morandi","year":"2008","unstructured":"Morandi F, Raffaghello L, Bianchi G, Meloni F, Salis A, Millo E, Ferrone S, Barnaba V, Pistoia V (2008) Immunogenicity of human mesenchymal stem cells in HLA-class I-restricted T cell responses against viral or tumor-associated antigens. Stem Cells 26:1275\u20131287","journal-title":"Stem Cells"},{"key":"584_CR96","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1634\/stemcells.2007-0554","volume":"26","author":"Z Selmani","year":"2008","unstructured":"Selmani Z, Naji A, Zidi I, Favier B, Gaiffe E, Obert L, Borg C, Saas P, Tiberghien P, Rouas-Freiss N, Carosella ED, Deschaseaux F (2008) Human leukocyte antigen-G5 secretion by human mesenchymal stem cells is required to suppress T lymphocyte and natural killer function and to induce CD4+ CD25high FOXP3+ regulatory T cells. Stem Cells 26:212\u2013222","journal-title":"Stem Cells"},{"key":"584_CR97","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/14653240802105299","volume":"10","author":"R Rizzo","year":"2008","unstructured":"Rizzo R, Campioni D, Stignani M, Melchiorri L, Bagnara GP, Bonsi L, Alviano F, Lanzoni G, Moretti S, Cuneo A, Lanza F, Baricordi OR (2008) A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells. Cytotherapy 10:364\u2013375","journal-title":"Cytotherapy"},{"key":"584_CR98","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3727\/000000006780666957","volume":"13","author":"A Nasef","year":"2007","unstructured":"Nasef A, Chapel A, Mazurier C, Bouchet S, Lopez M, Mathieu N, Sensebe L, Zhang Y, Gorin NC, Thierry D, Fouillard L (2007) Identification of IL-10 and TGF-beta transcripts involved in the inhibition of T-lymphocyte proliferation during cell contact with human mesenchymal stem cells. Gene Expr 13:217\u2013226","journal-title":"Gene Expr"},{"key":"584_CR99","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0041-1345(00)01047-2","volume":"32","author":"A Dorling","year":"2000","unstructured":"Dorling A, Monk N, Lechler R (2000) HLA-G inhibits the transendothelial cell migration of human NK cells: a strategy for inhibiting xenograft rejection. Transplant Proc 32:938","journal-title":"Transplant Proc"},{"key":"584_CR100","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1093\/humrep\/dep026","volume":"24","author":"J McCormick","year":"2009","unstructured":"McCormick J, Whitley GS, Le Bouteiller P, Cartwright JE (2009) Soluble HLA-G regulates motility and invasion of the trophoblast-derived cell line SGHPL-4. Hum Reprod 24:1339\u20131345","journal-title":"Hum Reprod"},{"key":"584_CR101","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/S0966-842X(00)01830-8","volume":"8","author":"A Alcami","year":"2000","unstructured":"Alcami A, Koszinowski UH (2000) Viral mechanisms of immune evasion. Trends Microbiol 8:410\u2013418","journal-title":"Trends Microbiol"},{"key":"584_CR102","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.humimm.2008.08.280","volume":"69","author":"ED Carosella","year":"2008","unstructured":"Carosella ED, HoWangYin KY, Favier B, LeMaoult J (2008) HLA-G-dependent suppressor cells: diverse by nature, function, and significance. Hum Immunol 69:700\u2013707","journal-title":"Hum Immunol"},{"key":"584_CR103","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1097\/QAD.0b013e32810c8bbc","volume":"21","author":"P Tripathi","year":"2007","unstructured":"Tripathi P, Agrawal S (2007) The role of human leukocyte antigen E and G in HIV infection. AIDS 21:1395\u20131404","journal-title":"AIDS"},{"key":"584_CR104","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/00002030-200202150-00005","volume":"16","author":"JM Lozano","year":"2002","unstructured":"Lozano JM, Gonzalez R, Kindelan JM, Rouas-Freiss N, Caballos R, Dausset J, Carosella ED, Pena J (2002) Monocytes and T-lymphocytes in HIV-1-positive patients express HLA-G molecule. AIDS 16:347\u2013351","journal-title":"AIDS"},{"key":"584_CR105","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.humimm.2003.08.353","volume":"64","author":"A Cabello","year":"2003","unstructured":"Cabello A, Rivero A, Garcia MJ, Lozano JM, Torre-Cisneros J, Gonzalez R, Duenas G, Galiani MD, Camacho A, Santamaria M, Solana R, Montero C, Kindelan JM, Pena J (2003) HAART induces the expression of HLA-G on peripheral monocytes in HIV-1 infected individuals. Hum Immunol 64:1045\u20131049","journal-title":"Hum Immunol"},{"key":"584_CR106","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.humimm.2006.10.014","volume":"68","author":"A Rivero","year":"2007","unstructured":"Rivero A, Lozano JM, Gonzalez R, Garcia-Jurado G, Camacho A, Torres-Cisneros J, Pena J (2007) Nucleoside reverse transcriptase inhibitors are able and protease inhibitors unable to induce the tolerogenic molecule HLA-G1 on monocytes from HIV-1 infected patients. Hum Immunol 68:303\u2013306","journal-title":"Hum Immunol"},{"key":"584_CR107","doi-asserted-by":"crossref","first-page":"3414","DOI":"10.1182\/blood-2006-06-030668","volume":"108","author":"S Adnan","year":"2006","unstructured":"Adnan S, Balamurugan A, Trocha A, Bennett MS, Ng HL, Ali A, Brander C, Yang OO (2006) Nef interference with HIV-1-specific CTL antiviral activity is epitope specific. Blood 108:3414\u20133419","journal-title":"Blood"},{"key":"584_CR108","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1016\/j.humimm.2004.07.239","volume":"65","author":"N Pizzato","year":"2004","unstructured":"Pizzato N, Derrien M, Lenfant F (2004) The short cytoplasmic tail of HLA-G determines its resistance to HIV-1 Nef-mediated cell surface downregulation. Hum Immunol 65:1389\u20131396","journal-title":"Hum Immunol"},{"key":"584_CR109","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/00002030-200402200-00008","volume":"18","author":"C Matte","year":"2004","unstructured":"Matte C, Lajoie J, Lacaille J, Zijenah LS, Ward BJ, Roger M (2004) Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 18:427\u2013431","journal-title":"AIDS"},{"key":"584_CR110","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1086\/498877","volume":"193","author":"J Lajoie","year":"2006","unstructured":"Lajoie J, Hargrove J, Zijenah LS, Humphrey JH, Ward BJ, Roger M (2006) Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J Infect Dis 193:298\u2013301","journal-title":"J Infect Dis"},{"key":"584_CR111","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1073\/pnas.0409676102","volume":"102","author":"CS Clements","year":"2005","unstructured":"Clements CS, Kjer-Nielsen L, Kostenko L, Hoare HL, Dunstone MA, Moses E, Freed K, Brooks AG, Rossjohn J, McCluskey J (2005) Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface. Proc Natl Acad Sci USA 102:3360\u20133365","journal-title":"Proc Natl Acad Sci USA"},{"key":"584_CR112","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1742-6405-3-28","volume":"3","author":"FO Aikhionbare","year":"2006","unstructured":"Aikhionbare FO, Kumaresan K, Shamsa F, Bond VC (2006) HLA-G DNA sequence variants and risk of perinatal HIV-1 transmission. AIDS Res Ther 3:28","journal-title":"AIDS Res Ther"},{"key":"584_CR113","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000053966","volume":"42","author":"C Soderberg-Naucler","year":"1999","unstructured":"Soderberg-Naucler C, Nelson JY (1999) Human cytomegalovirus latency and reactivation\u2014a delicate balance between the virus and its host\u2019s immune system. Intervirology 42:314\u2013321","journal-title":"Intervirology"},{"key":"584_CR114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/978-3-540-77349-8_19","volume":"325","author":"C Powers","year":"2008","unstructured":"Powers C, DeFilippis V, Malouli D, Fruh K (2008) Cytomegalovirus immune evasion. Curr Top Microbiol Immunol 325:333\u2013359","journal-title":"Curr Top Microbiol Immunol"},{"key":"584_CR115","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1086\/604733","volume":"200","author":"WH Yan","year":"2009","unstructured":"Yan WH, Lin A, Chen BG, Chen SY (2009) Induction of both membrane-bound and soluble HLA-G expression in active human cytomegalovirus infection. J Infect Dis 200:820\u2013826","journal-title":"J Infect Dis"},{"key":"584_CR116","doi-asserted-by":"crossref","first-page":"6808","DOI":"10.1128\/JVI.74.15.6808-6820.2000","volume":"74","author":"S Fisher","year":"2000","unstructured":"Fisher S, Genbacev O, Maidji E, Pereira L (2000) Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 74:6808\u20136820","journal-title":"J Virol"},{"key":"584_CR117","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4049\/jimmunol.164.2.805","volume":"164","author":"Y Jun","year":"2000","unstructured":"Jun Y, Kim E, Jin M, Sung HC, Han H, Geraghty DE, Ahn K (2000) Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 164:805\u2013811","journal-title":"J Immunol"},{"key":"584_CR118","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.humimm.2006.10.021","volume":"68","author":"H Wiendl","year":"2007","unstructured":"Wiendl H (2007) HLA-G in the nervous system. Hum Immunol 68:286\u2013293","journal-title":"Hum Immunol"},{"key":"584_CR119","doi-asserted-by":"crossref","first-page":"15226","DOI":"10.1128\/JVI.79.24.15226-15237.2005","volume":"79","author":"M Lafon","year":"2005","unstructured":"Lafon M, Prehaud C, Megret F, Lafage M, Mouillot G, Roa M, Moreau P, Rouas-Freiss N, Carosella ED (2005) Modulation of HLA-G expression in human neural cells after neurotropic viral infections. J Virol 79:15226\u201315237","journal-title":"J Virol"},{"key":"584_CR120","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1399-0039.2009.01331.x","volume":"74","author":"EA Cordero","year":"2009","unstructured":"Cordero EA, Veit TD, da Silva MA, Jacques SM, Silla LM, Chies JA (2009) HLA-G polymorphism influences the susceptibility to HCV infection in sickle cell disease patients. Tissue Antigens 74:308\u2013313","journal-title":"Tissue Antigens"},{"key":"584_CR121","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.humimm.2009.07.026","volume":"70","author":"F LeBouder","year":"2009","unstructured":"LeBouder F, Khoufache K, Menier C, Mandouri Y, Keffous M, Lejal N, Krawice-Radanne I, Carosella ED, Rouas-Freiss N, Riteau B (2009) Immunosuppressive HLA-G molecule is upregulated in alveolar epithelial cells after influenza A virus infection. Hum Immunol 70:1016\u20131019","journal-title":"Hum Immunol"},{"key":"584_CR122","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1034\/j.1600-0897.2003.00087.x","volume":"50","author":"N Pizzato","year":"2003","unstructured":"Pizzato N, Garmy-Susini B, Le Bouteiller P, Lenfant F (2003) Down-regulation of HLA-G1 cell surface expression in human cytomegalovirus infected cells. Am J Reprod Immunol 50:328\u2013333","journal-title":"Am J Reprod Immunol"},{"key":"584_CR123","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1002\/eji.200323912","volume":"33","author":"MT Barel","year":"2003","unstructured":"Barel MT, Pizzato N, van Leeuwen D, Bouteiller PL, Wiertz EJ, Lenfant F (2003) Amino acid composition of alpha1\/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. Eur J Immunol 33:1707\u20131716","journal-title":"Eur J Immunol"},{"key":"584_CR124","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.humimm.2006.12.003","volume":"68","author":"F Megret","year":"2007","unstructured":"Megret F, Prehaud C, Lafage M, Moreau P, Rouas-Freiss N, Carosella ED, Lafon M (2007) Modulation of HLA-G and HLA-E expression in human neuronal cells after rabies virus or herpes virus simplex type 1 infections. Hum Immunol 68:294\u2013302","journal-title":"Hum Immunol"},{"key":"584_CR125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1089\/vim.2009.0041","volume":"22","author":"JM Lozano","year":"2009","unstructured":"Lozano JM, Gonzalez R, Luque J, Frias M, Rivero A, Pena J (2009) CD8+ HLA-G+ regulatory T cells are expanded in HIV-1-infected patients. Viral Immunol 22:463\u2013465","journal-title":"Viral Immunol"},{"key":"584_CR126","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1099\/vir.0.79867-0","volume":"85","author":"M Derrien","year":"2004","unstructured":"Derrien M, Pizzato N, Dolcini G, Menu E, Chaouat G, Lenfant F, Barre-Sinoussi F, Bouteiller PL (2004) Human immunodeficiency virus-1 downregulates cell surface expression of the non-classical major histocompatibility class I molecule HLA-G1. J Gen Virol 85:1945\u20131954","journal-title":"J Gen Virol"},{"key":"584_CR127","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1365-2249.2006.03268.x","volume":"147","author":"L Donaghy","year":"2007","unstructured":"Donaghy L, Gros F, Amiot L, Mary C, Maillard A, Guiguen C, Gangneux JP (2007) Elevated levels of soluble non-classical major histocompatibility class I molecule human leucocyte antigen (HLA)-G in the blood of HIV-infected patients with or without visceral leishmaniasis. Clin Exp Immunol 147:236\u2013240","journal-title":"Clin Exp Immunol"},{"key":"584_CR128","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1097\/QAD.0b013e32832d0825","volume":"23","author":"J Lajoie","year":"2009","unstructured":"Lajoie J, Fontaine J, Tremblay C, Routy JP, Poudrier J, Roger M (2009) Persistence of high levels of blood soluble human leukocyte antigen-G is associated with rapid progression of HIV infection. AIDS 23:1437\u20131440","journal-title":"AIDS"},{"key":"584_CR129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.biocel.2003.11.001","volume":"36","author":"FP Barry","year":"2004","unstructured":"Barry FP, Murphy JM (2004) Mesenchymal stem cells: clinical applications and biological characterization. Int J Biochem Cell Biol 36:568\u2013584","journal-title":"Int J Biochem Cell Biol"},{"key":"584_CR130","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1365-2184.2007.00507.x","volume":"41","author":"PA Lysy","year":"2008","unstructured":"Lysy PA, Campard D, Smets F, Malaise J, Mourad M, Najimi M, Sokal EM (2008) Persistence of a chimerical phenotype after hepatocyte differentiation of human bone marrow mesenchymal stem cells. Cell Prolif 41:36\u201358","journal-title":"Cell Prolif"},{"key":"584_CR131","doi-asserted-by":"crossref","first-page":"717","DOI":"10.3727\/000000007783465154","volume":"16","author":"M Najimi","year":"2007","unstructured":"Najimi M, Khuu DN, Lysy PA, Jazouli N, Abarca J, Sempoux C, Sokal EM (2007) Adult derived human liver mesenchymal-like cells as a potential progenitors reservoir of hepatocytes? Cell Transplant 16:717\u2013728","journal-title":"Cell Transplant"},{"key":"584_CR132","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1053\/j.gastro.2007.12.024","volume":"134","author":"D Campard","year":"2008","unstructured":"Campard D, Lysy PA, Najimi M, Sokal EM (2008) Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 134:833\u2013848","journal-title":"Gastroenterology"},{"key":"584_CR133","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S0301-472X(01)00769-X","volume":"30","author":"A Bartholomew","year":"2002","unstructured":"Bartholomew A, Sturgeon C, Siatskas M, Ferrer K, McIntosh K, Patil S, Hardy W, Devine S, Ucker D, Deans R, Moseley A, Hoffman R (2002) Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol 30:42\u201348","journal-title":"Exp Hematol"},{"key":"584_CR134","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","volume":"363","author":"K Le Blanc","year":"2004","unstructured":"Le Blanc K, Rasmusson I, Sundberg B, Gotherstrom C, Hassan M, Uzunel M, Ringden O (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439\u20131441","journal-title":"Lancet"},{"key":"584_CR135","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2004-07-2921","volume":"105","author":"S Beyth","year":"2005","unstructured":"Beyth S, Borovsky Z, Mevorach D, Liebergall M, Gazit Z, Aslan H, Galun E, Rachmilewitz J (2005) Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T cell unresponsiveness. Blood 105:2214\u20132219","journal-title":"Blood"},{"key":"584_CR136","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1097\/TP.0b013e31819b3d72","volume":"87","author":"MJ Crop","year":"2009","unstructured":"Crop MJ, Baan CC, Korevaar SS, Ijzermans JN, Alwayn IP, Weimar W, Hoogduijn MJ (2009) Donor-derived mesenchymal stem cells suppress alloreactivity of kidney transplant patients. Transplantation 87:896\u2013906","journal-title":"Transplantation"},{"key":"584_CR137","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1016\/S0140-6736(08)60690-X","volume":"371","author":"K Le Blanc","year":"2008","unstructured":"Le Blanc K, Frassoni F, Ball L, Locatelli F, Roelofs H, Lewis I, Lanino E, Sundberg B, Bernardo ME, Remberger M, Dini G, Egeler RM, Bacigalupo A, Fibbe W, Ringd\u00e9n O, Developmental Committee of the European Group for Blood, Marrow Transplantation (2008) Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 371:1579\u20131586","journal-title":"Lancet"},{"key":"584_CR138","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3324\/haematol.2009.017038","volume":"95","author":"T H\u00fcgle","year":"2010","unstructured":"H\u00fcgle T, Daikeler T (2010) Stem cell transplantation for autoimmune diseases. Haematologica 95:185\u2013188","journal-title":"Haematologica"},{"key":"584_CR139","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1399-0039.2009.01438.x","volume":"75","author":"C Menier","year":"2009","unstructured":"Menier C, Rouas-Freiss N, Favier B, LeMaoult J, Moreau P, Carosella ED (2009) Recent advances on the non-classical major histocompatibility complex class I HLA-G molecule. Tissue Antigens 75:201\u2013206","journal-title":"Tissue Antigens"},{"key":"584_CR140","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1365-2249.2008.03598.x","volume":"152","author":"A Le Maux","year":"2008","unstructured":"Le Maux A, No\u00ebl G, Birebent B, Grosset J-M, Vu N, De Guibert S, Bernard M, Semana G, Amiot L (2008) Soluble human leucocyte antigen-G molecules in peripheral blood haematopoietic stem cell transplantation: a specific role to prevent acute graft-versus-host disease and a link with regulatory T cells. Clin Exp Immunol 152:50\u201356","journal-title":"Clin Exp Immunol"},{"key":"584_CR141","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/01.tp.0000267918.07906.08","volume":"84","author":"A Nasef","year":"2007","unstructured":"Nasef A, Mathieu N, Chapel A, Frickm J, Francois S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L (2007) Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G. Transplantation 84:231\u2013237","journal-title":"Transplantation"},{"key":"584_CR142","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1600-0897.2009.00707.x","volume":"62","author":"E Ivanova-Todorova","year":"2009","unstructured":"Ivanova-Todorova E, Mourdjeva M, Kyurkchiev D, Bochev I, Stoyanova E, Dimitrov R, Timeva T, Yunakova M, Bukarev D, Shterev A, Tivchev P, Kyurkiev S (2009) HLA-G expression is up-regulated by progesterone in mesenchymal stem cells. Am J Reprod Immunol 62:25\u201333","journal-title":"Am J Reprod Immunol"},{"key":"584_CR143","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/humrep\/dem326","volume":"23","author":"O Blanco","year":"2008","unstructured":"Blanco O, Tirado I, Munoz-Fernandez R, Abadia-Molina AC, Garcia-Pacheco JM, Pena J, Olivares EG (2008) Human decidual stromal cells express HLA-G: effects of cytokines and decidualization. Hum Reprod 23:144\u2013152","journal-title":"Hum Reprod"},{"key":"584_CR144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1751-553X.2007.00997.x","volume":"31","author":"A Nasef","year":"2009","unstructured":"Nasef A, Zhang YZ, Mazurier C, Bouchet S, Bensidhoum M, Francois S, Gorin C, Lopez M, Thierry D, Fouillard L, Chapel A (2009) Selected stro-1-enriched bone marrow stromal cells display a major suppressive effect on lymphocyte proliferation. Int J Lab Hem 31:9\u201319","journal-title":"Int J Lab Hem"},{"key":"584_CR145","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/cyto.b.20461","volume":"76","author":"D Campioni","year":"2009","unstructured":"Campioni D, Rizzo R, Stignani M, Melchiorri L, Ferrari L, Moretti S, Russo A, Bagnara GP, Bonsi L, Alviano F, Lanzoni G, Cuneo A, Baricordi OR, Lanza F (2009) A decreased positivity for CD90 on human mesenchymal stromal cells is associated with a loss of immunosuppressive activity by MSCs. Cytometry B Clin Cytom 76:225\u2013230","journal-title":"Cytometry B Clin Cytom"},{"key":"584_CR146","doi-asserted-by":"crossref","first-page":"2865","DOI":"10.1634\/stemcells.2007-1028","volume":"26","author":"ML Weiss","year":"2008","unstructured":"Weiss ML, Anderson C, Medicetty S, Seshareddy KB, Weiss RJ, VanderWerff I, Troyer D, McIntosh KR (2008) Immune properties of human umbilical cord warthon\u2019s jelly-derived cells. Stem cells 26:2865\u20132874","journal-title":"Stem cells"},{"key":"584_CR147","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00418-008-0519-3","volume":"131","author":"G La Rocca","year":"2009","unstructured":"La Rocca G, Anzalone R, Corrao S, Magno F, Loria T, Lo Iacono M, Di Stefano A, Giannuzzi P, Marasa L, Cappello F, Zummo G, Farina F (2009) Isolation and characterization of Oct-4+\/HLA-G+ mesenchymal stem cells from human umbilical cord matrix: differentiation potential and detection of new markers. Histochem Cell Biol 131:267\u2013282","journal-title":"Histochem Cell Biol"},{"key":"584_CR148","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.168.9.4772","volume":"168","author":"H Wiendl","year":"2002","unstructured":"Wiendl H, Mitsdoerffer M, Hofmeister V, Wischhusen J, Bornemann A, Meyermann R, Weiss EH, Melms A, Weller M (2002) A functional role of HLA-G expression in human gliomas: an alternative strategy of immune escape. J Immunol 168:4772\u20134780","journal-title":"J Immunol"}],"container-title":["Cellular and Molecular Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0584-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00018-010-0584-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00018-010-0584-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,4]],"date-time":"2023-06-04T06:25:24Z","timestamp":1685859924000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00018-010-0584-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,16]]},"references-count":148,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["584"],"URL":"https:\/\/doi.org\/10.1007\/s00018-010-0584-3","relation":{},"ISSN":["1420-682X","1420-9071"],"issn-type":[{"value":"1420-682X","type":"print"},{"value":"1420-9071","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,16]]}}}